Cargando…
Commercialized artemisinin derivatives combined with colistin protect against critical Gram-negative bacterial infection
The emergence and spread of the mcr-1 gene and its mutants has immensely compromised the efficient usage of colistin for the treatment of drug-resistant Gram-negative bacterial infection in clinical settings. However, there are currently no clinically available colistin synergis. Here we identify ar...
Autores principales: | Zhou, Yonglin, Liu, Baichen, Chu, Xiuling, Su, Jianqing, Xu, Lei, Li, Li, Deng, Xuming, Li, Dan, Lv, Qianghua, Wang, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458715/ https://www.ncbi.nlm.nih.gov/pubmed/36076060 http://dx.doi.org/10.1038/s42003-022-03898-5 |
Ejemplares similares
-
Isoalantolactone restores the sensitivity of gram‐negative Enterobacteriaceae carrying MCR‐1 to carbapenems
por: Lu, Na, et al.
Publicado: (2020) -
Polyphosphate Kinase Is Required for the Processes of Virulence and Persistence in Acinetobacter baumannii
por: Lv, Hongfa, et al.
Publicado: (2022) -
Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria
por: Feng, Xiaoxuan, et al.
Publicado: (2021) -
Synergistic Effect of Lithocholic Acid with Gentamicin against Gram-Positive Bacteria but Not against Gram-Negative Bacteria
por: Lv, Hongfa, et al.
Publicado: (2022) -
Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens
por: Cannatelli, Antonio, et al.
Publicado: (2018)